Business Opportunities and Investment Strategies for Global Pain Management Drugs Market 2023-2033
Opportunity and Strategy Analysis
This report focuses on identifying opportunities and strategies for investing in the global pain management drugs market within the forecast period. It provides a complete analysis of the global market both quantitatively and qualitatively. The quantitative analysis includes market size and revenue data of the total demand, sub-markets, and regional/national levels throughout 2023-2033. Qualitative analysis depicts a full picture of market dynamics and trends including drivers, restraints and challenges, emerging products/market trends, and Porter’s Fiver Forces analysis.
Based on the market data and analysis, the report highlights Increasingly Attractive Segments (IAS) and business opportunities in each segmentation. Moreover, a systematic evaluation of Internal Risks (factors arising within the industry development) and External Risks (factors arising from the surrounding environments) is provided for the pain management drugs industry and market. All the identified risk factors are measured quantitatively according to GMD’s novel numeric system, i.e. each risk is evaluated with GMD Risk Index Number (GMD RIN) and GMD Risk Intensity Level (GMD RIL). This in-depth risk assessment offers a comprehensive understanding of the current risk factors and their developing trends. Furthermore, this report concludes risk management strategies and Critical Success Factors (CSFs) to help companies make intelligence-based business decisions in the global pain management drugs industry.
Market Coverage & Overview
The report is based on studies for 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. Considering impact of COVID-19 and regional conflicts such as Russia-Ukraine war, the trend and outlook of global market is forecast in optimistic, balanced, and conservative scenarios. In the balanced view, the global pain management drugs market is expected to reach $121 billion by 2033, growing by 4.3% annually over the coming years.
Segmentation Analysis
Highlighted with 89 tables and 103 figures, this 187-page report represents a 360-degree view on the global market with extensively detailed segmentations by Product, Pain Type, Drug Type, Route of Administration, Application, Distribution Channel, and Region/Country as shown below. Annual revenue 2023-2033 for each segment is included in the report.
By Product
Key Companies
The report also covers the current competitive scenario and profiles key vendors including market leaders and important emerging players. A selection of companies profiled in this report includes:
This report focuses on identifying opportunities and strategies for investing in the global pain management drugs market within the forecast period. It provides a complete analysis of the global market both quantitatively and qualitatively. The quantitative analysis includes market size and revenue data of the total demand, sub-markets, and regional/national levels throughout 2023-2033. Qualitative analysis depicts a full picture of market dynamics and trends including drivers, restraints and challenges, emerging products/market trends, and Porter’s Fiver Forces analysis.
Based on the market data and analysis, the report highlights Increasingly Attractive Segments (IAS) and business opportunities in each segmentation. Moreover, a systematic evaluation of Internal Risks (factors arising within the industry development) and External Risks (factors arising from the surrounding environments) is provided for the pain management drugs industry and market. All the identified risk factors are measured quantitatively according to GMD’s novel numeric system, i.e. each risk is evaluated with GMD Risk Index Number (GMD RIN) and GMD Risk Intensity Level (GMD RIL). This in-depth risk assessment offers a comprehensive understanding of the current risk factors and their developing trends. Furthermore, this report concludes risk management strategies and Critical Success Factors (CSFs) to help companies make intelligence-based business decisions in the global pain management drugs industry.
Market Coverage & Overview
The report is based on studies for 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. Considering impact of COVID-19 and regional conflicts such as Russia-Ukraine war, the trend and outlook of global market is forecast in optimistic, balanced, and conservative scenarios. In the balanced view, the global pain management drugs market is expected to reach $121 billion by 2033, growing by 4.3% annually over the coming years.
Segmentation Analysis
Highlighted with 89 tables and 103 figures, this 187-page report represents a 360-degree view on the global market with extensively detailed segmentations by Product, Pain Type, Drug Type, Route of Administration, Application, Distribution Channel, and Region/Country as shown below. Annual revenue 2023-2033 for each segment is included in the report.
By Product
- Opioids
- NSAIDS
- Anesthetics
- Anticonvulsants
- Anti-depressants
- Non-narcotic Analgesics
- Chronic Pain
- Acute Pain
- Generic Drugs
- Branded Drugs
- Oral
- Parental
- Neuropathic Pain
- Cancer Pain
- Facial Pain and Migraine
- Musculoskeletal Pain
- Post-operative Pain
- Chronic Back Pain
- Arthritic Pain
- Other Applications
- Hospitals Pharmacy
- Online Pharmacy
- Retail Pharmacy
- North America (U.S., Canada, and Mexico)
- Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
- APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
- South America (Brazil, Chile, Argentina, Rest of South America)
- MEA (UAE, Saudi Arabia, South Africa, and Rest of MEA)
Key Companies
The report also covers the current competitive scenario and profiles key vendors including market leaders and important emerging players. A selection of companies profiled in this report includes:
- Abbott Laboratories Inc.
- Baxter International Inc.
- Boehringer Ingelheim International GmbH
- Eli Lilly & Company
- GlaxoSmithKline PLC
- Johnson & Johnson
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Purdue Pharma L.P
- Teva Pharmaceutical Industries Ltd.
1 INTRODUCTION
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.1.3 Impact of Russia-Ukraine Conflict
2.1.4 Impact of Israel-Palestine War
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF GLOBAL MARKET BY PRODUCT
3.1 Market Overview by Product
3.2 Opioids
3.3 NSAIDS
3.4 Anesthetics
3.5 Anticonvulsants
3.6 Anti-depressants
3.7 Non-narcotic Analgesics
4 SEGMENTATION OF GLOBAL MARKET BY PAIN TYPE
4.1 Market Overview by Pain Type
4.2 Chronic Pain
4.3 Acute Pain
5 SEGMENTATION OF GLOBAL MARKET BY DRUG TYPE
5.1 Market Overview by Drug Type
5.2 Generic Drugs
5.3 Branded Drugs
6 SEGMENTATION OF GLOBAL MARKET BY ROUTE OF ADMINISTRATION
6.1 Market Overview by Route of Administration
6.2 Oral
6.3 Parental
7 SEGMENTATION OF GLOBAL MARKET BY APPLICATION
7.1 Market Overview by Application
7.2 Neuropathic Pain
7.3 Cancer Pain
7.4 Facial Pain and Migraine
7.5 Musculoskeletal Pain
7.6 Post-operative Pain
7.7 Chronic Back Pain
7.8 Arthritic Pain
7.9 Other Applications
8 SEGMENTATION OF GLOBAL MARKET BY DISTRIBUTION CHANNEL
8.1 Market Overview by Distribution Channel
8.2 Hospitals Pharmacy
8.3 Online Pharmacy
8.4 Retail Pharmacy
9 SEGMENTATION OF GLOBAL MARKET BY REGION
9.1 Geographic Market Overview 2023-2033
9.2 North America Market 2023-2033 by Country
9.2.1 Overview of North America Market
9.2.2 U.S.
9.2.3 Canada
9.2.4 Mexico
9.3 European Market 2023-2033 by Country
9.3.1 Overview of European Market
9.3.2 Germany
9.3.3 U.K.
9.3.4 France
9.3.5 Spain
9.3.6 Italy
9.3.7 Russia
9.3.8 Rest of European Market
9.4 Asia-Pacific Market 2023-2033 by Country
9.4.1 Overview of Asia-Pacific Market
9.4.2 Japan
9.4.3 China
9.4.4 Australia
9.4.5 India
9.4.6 South Korea
9.4.7 Rest of APAC Region
9.5 South America Market 2023-2033 by Country
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America Market
9.6 MEA Market 2023-2033 by Country
9.6.1 UAE
9.6.2 Saudi Arabia
9.6.3 South Africa
9.6.4 Other National Markets
10 COMPETITIVE LANDSCAPE
10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
Abbott Laboratories Inc.
Baxter International Inc.
Boehringer Ingelheim International GmbH
Eli Lilly & Company
GlaxoSmithKline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Purdue Pharma L.P
Teva Pharmaceutical Industries Ltd.
11 INVESTING IN PAIN MANAGEMENT DRUGS INDUSTRY: RISK ASSESSMENT AND MANAGEMENT
11.1 Risk Evaluation of Global Market
11.2 Critical Success Factors (CSFs)
RELATED REPORTS
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.1.3 Impact of Russia-Ukraine Conflict
2.1.4 Impact of Israel-Palestine War
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF GLOBAL MARKET BY PRODUCT
3.1 Market Overview by Product
3.2 Opioids
3.3 NSAIDS
3.4 Anesthetics
3.5 Anticonvulsants
3.6 Anti-depressants
3.7 Non-narcotic Analgesics
4 SEGMENTATION OF GLOBAL MARKET BY PAIN TYPE
4.1 Market Overview by Pain Type
4.2 Chronic Pain
4.3 Acute Pain
5 SEGMENTATION OF GLOBAL MARKET BY DRUG TYPE
5.1 Market Overview by Drug Type
5.2 Generic Drugs
5.3 Branded Drugs
6 SEGMENTATION OF GLOBAL MARKET BY ROUTE OF ADMINISTRATION
6.1 Market Overview by Route of Administration
6.2 Oral
6.3 Parental
7 SEGMENTATION OF GLOBAL MARKET BY APPLICATION
7.1 Market Overview by Application
7.2 Neuropathic Pain
7.3 Cancer Pain
7.4 Facial Pain and Migraine
7.5 Musculoskeletal Pain
7.6 Post-operative Pain
7.7 Chronic Back Pain
7.8 Arthritic Pain
7.9 Other Applications
8 SEGMENTATION OF GLOBAL MARKET BY DISTRIBUTION CHANNEL
8.1 Market Overview by Distribution Channel
8.2 Hospitals Pharmacy
8.3 Online Pharmacy
8.4 Retail Pharmacy
9 SEGMENTATION OF GLOBAL MARKET BY REGION
9.1 Geographic Market Overview 2023-2033
9.2 North America Market 2023-2033 by Country
9.2.1 Overview of North America Market
9.2.2 U.S.
9.2.3 Canada
9.2.4 Mexico
9.3 European Market 2023-2033 by Country
9.3.1 Overview of European Market
9.3.2 Germany
9.3.3 U.K.
9.3.4 France
9.3.5 Spain
9.3.6 Italy
9.3.7 Russia
9.3.8 Rest of European Market
9.4 Asia-Pacific Market 2023-2033 by Country
9.4.1 Overview of Asia-Pacific Market
9.4.2 Japan
9.4.3 China
9.4.4 Australia
9.4.5 India
9.4.6 South Korea
9.4.7 Rest of APAC Region
9.5 South America Market 2023-2033 by Country
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America Market
9.6 MEA Market 2023-2033 by Country
9.6.1 UAE
9.6.2 Saudi Arabia
9.6.3 South Africa
9.6.4 Other National Markets
10 COMPETITIVE LANDSCAPE
10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
Abbott Laboratories Inc.
Baxter International Inc.
Boehringer Ingelheim International GmbH
Eli Lilly & Company
GlaxoSmithKline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Purdue Pharma L.P
Teva Pharmaceutical Industries Ltd.
11 INVESTING IN PAIN MANAGEMENT DRUGS INDUSTRY: RISK ASSESSMENT AND MANAGEMENT
11.1 Risk Evaluation of Global Market
11.2 Critical Success Factors (CSFs)
RELATED REPORTS
LIST OF TABLES
Table 1. Snapshot of Global Pain Management Drugs Market in Balanced Perspective, 2023-2033
Table 2. World Economic Outlook, 2024-2036
Table 3. World Economic Outlook, 2022-2024
Table 4. Scenarios for Economic Impact of Ukraine Crisis
Table 5. Scenarios for Economic Impact of Israel-Palestine War
Table 6. World Health Spending by Region, $ bn, 2013-2020
Table 7. Main Product Trends and Market Opportunities in Global Pain Management Drugs Market
Table 8. Global Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 9. Global Pain Management Drugs Market by Pain Type, 2023-2033, $ mn
Table 10. Global Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 11. Global Pain Management Drugs Market by Route of Administration, 2023-2033, $ mn
Table 12. Global Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 13. Global Pain Management Drugs Market by Distribution Channel, 2023-2033, $ mn
Table 14. Global Pain Management Drugs Market by Region, 2023-2033, $ mn
Table 15. Leading National Pain Management Drugs Market, 2023 and 2033, $ mn
Table 16. North America Pain Management Drugs Market by Country, 2023-2033, $ mn
Table 17. U.S. Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 18. U.S. Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 19. U.S. Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 20. Canada Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 21. Canada Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 22. Canada Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 23. Mexico Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 24. Mexico Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 25. Mexico Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 26. Europe Pain Management Drugs Market by Country, 2023-2033, $ mn
Table 27. Germany Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 28. Germany Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 29. Germany Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 30. U.K. Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 31. U.K. Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 32. U.K. Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 33. France Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 34. France Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 35. France Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 36. Spain Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 37. Spain Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 38. Spain Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 39. Italy Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 40. Italy Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 41. Italy Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 42. Russia Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 43. Russia Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 44. Russia Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 45. Pain Management Drugs Market in Rest of Europe by Country, 2023-2033, $ mn
Table 46. APAC Pain Management Drugs Market by Country, 2023-2033, $ mn
Table 47. Japan Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 48. Japan Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 49. Japan Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 50. China Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 51. China Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 52. China Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 53. Australia Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 54. Australia Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 55. Australia Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 56. India Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 57. India Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 58. India Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 59. South Korea Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 60. South Korea Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 61. South Korea Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 62. Pain Management Drugs Market in Rest of APAC by Country/Region, 2023-2033, $ mn
Table 63. South America Pain Management Drugs Market by Country, 2023-2033, $ mn
Table 64. Argentina Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 65. Argentina Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 66. Argentina Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 67. Brazil Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 68. Brazil Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 69. Brazil Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 70. Chile Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 71. Chile Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 72. Chile Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 73. MEA Pain Management Drugs Market by Country, 2023-2033, $ mn
Table 74. UAE Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 75. UAE Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 76. UAE Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 77. Saudi Arabia Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 78. Saudi Arabia Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 79. Saudi Arabia Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 80. South Africa Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 81. South Africa Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 82. South Africa Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 83. Abbott Laboratories Inc.: Company Snapshot
Table 84. Abbott Laboratories Inc.: Business Segmentation
Table 85. Abbott Laboratories Inc.: Product Portfolio
Table 86. List of Risk Factors and Weight Percentages/Theoretical Maximum
Table 87. Definition of GMD Relative Risk Index Number (Relative RIN) and GMD Risk Intensity Level (RIL)
Table 88. Risk Evaluation for Investing in Global Market, 2023-2033
Table 89. Critical Success Factors and Key Takeaways
Table 1. Snapshot of Global Pain Management Drugs Market in Balanced Perspective, 2023-2033
Table 2. World Economic Outlook, 2024-2036
Table 3. World Economic Outlook, 2022-2024
Table 4. Scenarios for Economic Impact of Ukraine Crisis
Table 5. Scenarios for Economic Impact of Israel-Palestine War
Table 6. World Health Spending by Region, $ bn, 2013-2020
Table 7. Main Product Trends and Market Opportunities in Global Pain Management Drugs Market
Table 8. Global Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 9. Global Pain Management Drugs Market by Pain Type, 2023-2033, $ mn
Table 10. Global Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 11. Global Pain Management Drugs Market by Route of Administration, 2023-2033, $ mn
Table 12. Global Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 13. Global Pain Management Drugs Market by Distribution Channel, 2023-2033, $ mn
Table 14. Global Pain Management Drugs Market by Region, 2023-2033, $ mn
Table 15. Leading National Pain Management Drugs Market, 2023 and 2033, $ mn
Table 16. North America Pain Management Drugs Market by Country, 2023-2033, $ mn
Table 17. U.S. Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 18. U.S. Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 19. U.S. Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 20. Canada Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 21. Canada Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 22. Canada Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 23. Mexico Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 24. Mexico Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 25. Mexico Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 26. Europe Pain Management Drugs Market by Country, 2023-2033, $ mn
Table 27. Germany Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 28. Germany Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 29. Germany Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 30. U.K. Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 31. U.K. Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 32. U.K. Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 33. France Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 34. France Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 35. France Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 36. Spain Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 37. Spain Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 38. Spain Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 39. Italy Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 40. Italy Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 41. Italy Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 42. Russia Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 43. Russia Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 44. Russia Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 45. Pain Management Drugs Market in Rest of Europe by Country, 2023-2033, $ mn
Table 46. APAC Pain Management Drugs Market by Country, 2023-2033, $ mn
Table 47. Japan Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 48. Japan Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 49. Japan Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 50. China Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 51. China Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 52. China Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 53. Australia Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 54. Australia Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 55. Australia Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 56. India Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 57. India Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 58. India Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 59. South Korea Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 60. South Korea Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 61. South Korea Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 62. Pain Management Drugs Market in Rest of APAC by Country/Region, 2023-2033, $ mn
Table 63. South America Pain Management Drugs Market by Country, 2023-2033, $ mn
Table 64. Argentina Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 65. Argentina Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 66. Argentina Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 67. Brazil Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 68. Brazil Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 69. Brazil Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 70. Chile Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 71. Chile Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 72. Chile Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 73. MEA Pain Management Drugs Market by Country, 2023-2033, $ mn
Table 74. UAE Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 75. UAE Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 76. UAE Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 77. Saudi Arabia Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 78. Saudi Arabia Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 79. Saudi Arabia Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 80. South Africa Pain Management Drugs Market by Product, 2023-2033, $ mn
Table 81. South Africa Pain Management Drugs Market by Drug Type, 2023-2033, $ mn
Table 82. South Africa Pain Management Drugs Market by Application, 2023-2033, $ mn
Table 83. Abbott Laboratories Inc.: Company Snapshot
Table 84. Abbott Laboratories Inc.: Business Segmentation
Table 85. Abbott Laboratories Inc.: Product Portfolio
Table 86. List of Risk Factors and Weight Percentages/Theoretical Maximum
Table 87. Definition of GMD Relative Risk Index Number (Relative RIN) and GMD Risk Intensity Level (RIL)
Table 88. Risk Evaluation for Investing in Global Market, 2023-2033
Table 89. Critical Success Factors and Key Takeaways
LIST OF FIGURES
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033
Figure 4. Global Pain Management Drugs Market, 2023-2033, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Pain Management Drugs Market
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060
Figure 9. Primary Restraints and Impact Factors of Global Pain Management Drugs Market
Figure 10. Porter’s Fiver Forces Analysis of Global Pain Management Drugs Market
Figure 11. Growth Opportunity Analysis by Product
Figure 12. Breakdown of Global Pain Management Drugs Market by Product, 2023-2033, % of Revenue
Figure 13. Global Addressable Market Cap in 2024-2033 by Product, Value ($ mn) and Share (%)
Figure 14. Global Pain Management Drugs Market by Product: Opioids, 2023-2033, $ mn
Figure 15. Global Pain Management Drugs Market by Product: NSAIDS, 2023-2033, $ mn
Figure 16. Global Pain Management Drugs Market by Product: Anesthetics, 2023-2033, $ mn
Figure 17. Global Pain Management Drugs Market by Product: Anticonvulsants, 2023-2033, $ mn
Figure 18. Global Pain Management Drugs Market by Product: Anti-depressants, 2023-2033, $ mn
Figure 19. Global Pain Management Drugs Market by Product: Non-narcotic Analgesics, 2023-2033, $ mn
Figure 20. Growth Opportunity Analysis by Pain Type
Figure 21. Breakdown of Global Pain Management Drugs Market by Pain Type, 2023-2033, % of Sales Revenue
Figure 22. Global Addressable Market Cap in 2024-2033 by Pain Type, Value ($ mn) and Share (%)
Figure 23. Global Pain Management Drugs Market by Pain Type: Chronic Pain, 2023-2033, $ mn
Figure 24. Global Pain Management Drugs Market by Pain Type: Acute Pain, 2023-2033, $ mn
Figure 25. Growth Opportunity Analysis by Drug Type
Figure 26. Breakdown of Global Pain Management Drugs Market by Drug Type, 2023-2033, % of Sales Revenue
Figure 27. Global Addressable Market Cap in 2024-2033 by Drug Type, Value ($ mn) and Share (%)
Figure 28. Global Pain Management Drugs Market by Drug Type: Generic Drugs, 2023-2033, $ mn
Figure 29. Global Pain Management Drugs Market by Drug Type: Branded Drugs, 2023-2033, $ mn
Figure 30. Growth Opportunity Analysis by Route of Administration
Figure 31. Breakdown of Global Pain Management Drugs Market by Route of Administration, 2023-2033, % of Revenue
Figure 32. Global Addressable Market Cap in 2024-2033 by Route of Administration, Value ($ mn) and Share (%)
Figure 33. Global Pain Management Drugs Market by Route of Administration: Oral, 2023-2033, $ mn
Figure 34. Global Pain Management Drugs Market by Route of Administration: Parental, 2023-2033, $ mn
Figure 35. Growth Opportunity Analysis by Application
Figure 36. Breakdown of Global Pain Management Drugs Market by Application, 2023-2033, % of Revenue
Figure 37. Global Addressable Market Cap in 2024-2033 by Application, Value ($ mn) and Share (%)
Figure 38. Global Pain Management Drugs Market by Application: Neuropathic Pain, 2023-2033, $ mn
Figure 39. Global Pain Management Drugs Market by Application: Cancer Pain, 2023-2033, $ mn
Figure 40. Global Pain Management Drugs Market by Application: Facial Pain and Migraine, 2023-2033, $ mn
Figure 41. Global Pain Management Drugs Market by Application: Musculoskeletal Pain, 2023-2033, $ mn
Figure 42. Global Pain Management Drugs Market by Application: Post-operative Pain, 2023-2033, $ mn
Figure 43. Global Pain Management Drugs Market by Application: Chronic Back Pain, 2023-2033, $ mn
Figure 44. Global Pain Management Drugs Market by Application: Arthritic Pain, 2023-2033, $ mn
Figure 45. Global Pain Management Drugs Market by Application: Other Applications, 2023-2033, $ mn
Figure 46. Growth Opportunity Analysis by Distribution Channel
Figure 47. Breakdown of Global Pain Management Drugs Market by Distribution Channel, 2023-2033, % of Revenue
Figure 48. Global Addressable Market Cap in 2024-2033 by Distribution Channel, Value ($ mn) and Share (%)
Figure 49. Global Pain Management Drugs Market by Distribution Channel: Hospitals Pharmacy, 2023-2033, $ mn
Figure 50. Global Pain Management Drugs Market by Distribution Channel: Online Pharmacy, 2023-2033, $ mn
Figure 51. Global Pain Management Drugs Market by Distribution Channel: Retail Pharmacy, 2023-2033, $ mn
Figure 52. Global Market Snapshot by Region
Figure 53. Growth Opportunity Analysis of Global Market by Region
Figure 54. Geographic Spread of Worldwide Pain Management Drugs Market, 2023-2033, % of Sales Revenue
Figure 55. Global Addressable Market Cap in 2024-2033 by Region, Value ($ mn) and Share (%)
Figure 56. North American Pain Management Drugs Market, 2023-2033, $ mn
Figure 57. Growth Opportunity Analysis of North America Market by Country
Figure 58. Breakdown of North America Pain Management Drugs Market by Country, 2023 and 2033, % of Revenue
Figure 59. Contribution to North America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 60. U.S. Pain Management Drugs Market, 2023-2033, $ mn
Figure 61. Canada Pain Management Drugs Market, 2023-2033, $ mn
Figure 62. Pain Management Drugs Market in Mexico, 2023-2033, $ mn
Figure 63. European Pain Management Drugs Market, 2023-2033, $ mn
Figure 64. Growth Opportunity Analysis of Europe Market by Country
Figure 65. Breakdown of European Pain Management Drugs Market by Country, 2023 and 2033, % of Revenue
Figure 66. Contribution to Europe 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 67. Pain Management Drugs Market in Germany, 2023-2033, $ mn
Figure 68. Pain Management Drugs Market in U.K., 2023-2033, $ mn
Figure 69. Pain Management Drugs Market in France, 2023-2033, $ mn
Figure 70. Pain Management Drugs Market in Spain, 2023-2033, $ mn
Figure 71. Pain Management Drugs Market in Italy, 2023-2033, $ mn
Figure 72. Pain Management Drugs Market in Russia, 2023-2033, $ mn
Figure 73. Pain Management Drugs Market in Rest of Europe, 2023-2033, $ mn
Figure 74. Asia-Pacific Pain Management Drugs Market, 2023-2033, $ mn
Figure 75. Growth Opportunity Analysis of Asia-Pacific Market by Country
Figure 76. Breakdown of APAC Pain Management Drugs Market by Country, 2023 and 2033, % of Revenue
Figure 77. Contribution to APAC 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 78. Pain Management Drugs Market in Japan, 2023-2033, $ mn
Figure 79. Pain Management Drugs Market in China, 2023-2033, $ mn
Figure 80. Pain Management Drugs Market in Australia, 2023-2033, $ mn
Figure 81. Pain Management Drugs Market in India, 2023-2033, $ mn
Figure 82. Pain Management Drugs Market in South Korea, 2023-2033, $ mn
Figure 83. Pain Management Drugs Market in Rest of APAC, 2023-2033, $ mn
Figure 84. South America Pain Management Drugs Market, 2023-2033, $ mn
Figure 85. Growth Opportunity Analysis of South America Market by Country
Figure 86. Breakdown of South America Pain Management Drugs Market by Country, 2023 and 2033, % of Revenue
Figure 87. Contribution to South America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 88. Pain Management Drugs Market in Argentina, 2023-2033, $ mn
Figure 89. Pain Management Drugs Market in Brazil, 2023-2033, $ mn
Figure 90. Pain Management Drugs Market in Chile, 2023-2033, $ mn
Figure 91. Pain Management Drugs Market in Rest of South America, 2023-2033, $ mn
Figure 92. Pain Management Drugs Market in Middle East and Africa (MEA), 2023-2033, $ mn
Figure 93. Growth Opportunity Analysis of MEA Market by Country
Figure 94. Breakdown of MEA Pain Management Drugs Market by Country, 2023 and 2033, % of Revenue
Figure 95. Contribution to MEA 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 96. Pain Management Drugs Market in UAE, 2023-2033, $ mn
Figure 97. Pain Management Drugs Market in Saudi Arabia, 2023-2033, $ mn
Figure 98. Pain Management Drugs Market in South Africa, 2023-2033, $ mn
Figure 99. Pain Management Drugs Market in the Rest of MEA, 2023-2033, $ mn
Figure 100. Growth Stage of Global Pain Management Drugs Industry over the Forecast Period
Figure 101. Comparison of Risk Factors by GMD RIN in 2023
Figure 102. GMD Relative RIN of Internal Risk Factors in 2023 on Radar Chart
Figure 103. GMD Relative RIN of External Risk Factors in 2023 on Radar Chart
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033
Figure 4. Global Pain Management Drugs Market, 2023-2033, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Pain Management Drugs Market
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060
Figure 9. Primary Restraints and Impact Factors of Global Pain Management Drugs Market
Figure 10. Porter’s Fiver Forces Analysis of Global Pain Management Drugs Market
Figure 11. Growth Opportunity Analysis by Product
Figure 12. Breakdown of Global Pain Management Drugs Market by Product, 2023-2033, % of Revenue
Figure 13. Global Addressable Market Cap in 2024-2033 by Product, Value ($ mn) and Share (%)
Figure 14. Global Pain Management Drugs Market by Product: Opioids, 2023-2033, $ mn
Figure 15. Global Pain Management Drugs Market by Product: NSAIDS, 2023-2033, $ mn
Figure 16. Global Pain Management Drugs Market by Product: Anesthetics, 2023-2033, $ mn
Figure 17. Global Pain Management Drugs Market by Product: Anticonvulsants, 2023-2033, $ mn
Figure 18. Global Pain Management Drugs Market by Product: Anti-depressants, 2023-2033, $ mn
Figure 19. Global Pain Management Drugs Market by Product: Non-narcotic Analgesics, 2023-2033, $ mn
Figure 20. Growth Opportunity Analysis by Pain Type
Figure 21. Breakdown of Global Pain Management Drugs Market by Pain Type, 2023-2033, % of Sales Revenue
Figure 22. Global Addressable Market Cap in 2024-2033 by Pain Type, Value ($ mn) and Share (%)
Figure 23. Global Pain Management Drugs Market by Pain Type: Chronic Pain, 2023-2033, $ mn
Figure 24. Global Pain Management Drugs Market by Pain Type: Acute Pain, 2023-2033, $ mn
Figure 25. Growth Opportunity Analysis by Drug Type
Figure 26. Breakdown of Global Pain Management Drugs Market by Drug Type, 2023-2033, % of Sales Revenue
Figure 27. Global Addressable Market Cap in 2024-2033 by Drug Type, Value ($ mn) and Share (%)
Figure 28. Global Pain Management Drugs Market by Drug Type: Generic Drugs, 2023-2033, $ mn
Figure 29. Global Pain Management Drugs Market by Drug Type: Branded Drugs, 2023-2033, $ mn
Figure 30. Growth Opportunity Analysis by Route of Administration
Figure 31. Breakdown of Global Pain Management Drugs Market by Route of Administration, 2023-2033, % of Revenue
Figure 32. Global Addressable Market Cap in 2024-2033 by Route of Administration, Value ($ mn) and Share (%)
Figure 33. Global Pain Management Drugs Market by Route of Administration: Oral, 2023-2033, $ mn
Figure 34. Global Pain Management Drugs Market by Route of Administration: Parental, 2023-2033, $ mn
Figure 35. Growth Opportunity Analysis by Application
Figure 36. Breakdown of Global Pain Management Drugs Market by Application, 2023-2033, % of Revenue
Figure 37. Global Addressable Market Cap in 2024-2033 by Application, Value ($ mn) and Share (%)
Figure 38. Global Pain Management Drugs Market by Application: Neuropathic Pain, 2023-2033, $ mn
Figure 39. Global Pain Management Drugs Market by Application: Cancer Pain, 2023-2033, $ mn
Figure 40. Global Pain Management Drugs Market by Application: Facial Pain and Migraine, 2023-2033, $ mn
Figure 41. Global Pain Management Drugs Market by Application: Musculoskeletal Pain, 2023-2033, $ mn
Figure 42. Global Pain Management Drugs Market by Application: Post-operative Pain, 2023-2033, $ mn
Figure 43. Global Pain Management Drugs Market by Application: Chronic Back Pain, 2023-2033, $ mn
Figure 44. Global Pain Management Drugs Market by Application: Arthritic Pain, 2023-2033, $ mn
Figure 45. Global Pain Management Drugs Market by Application: Other Applications, 2023-2033, $ mn
Figure 46. Growth Opportunity Analysis by Distribution Channel
Figure 47. Breakdown of Global Pain Management Drugs Market by Distribution Channel, 2023-2033, % of Revenue
Figure 48. Global Addressable Market Cap in 2024-2033 by Distribution Channel, Value ($ mn) and Share (%)
Figure 49. Global Pain Management Drugs Market by Distribution Channel: Hospitals Pharmacy, 2023-2033, $ mn
Figure 50. Global Pain Management Drugs Market by Distribution Channel: Online Pharmacy, 2023-2033, $ mn
Figure 51. Global Pain Management Drugs Market by Distribution Channel: Retail Pharmacy, 2023-2033, $ mn
Figure 52. Global Market Snapshot by Region
Figure 53. Growth Opportunity Analysis of Global Market by Region
Figure 54. Geographic Spread of Worldwide Pain Management Drugs Market, 2023-2033, % of Sales Revenue
Figure 55. Global Addressable Market Cap in 2024-2033 by Region, Value ($ mn) and Share (%)
Figure 56. North American Pain Management Drugs Market, 2023-2033, $ mn
Figure 57. Growth Opportunity Analysis of North America Market by Country
Figure 58. Breakdown of North America Pain Management Drugs Market by Country, 2023 and 2033, % of Revenue
Figure 59. Contribution to North America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 60. U.S. Pain Management Drugs Market, 2023-2033, $ mn
Figure 61. Canada Pain Management Drugs Market, 2023-2033, $ mn
Figure 62. Pain Management Drugs Market in Mexico, 2023-2033, $ mn
Figure 63. European Pain Management Drugs Market, 2023-2033, $ mn
Figure 64. Growth Opportunity Analysis of Europe Market by Country
Figure 65. Breakdown of European Pain Management Drugs Market by Country, 2023 and 2033, % of Revenue
Figure 66. Contribution to Europe 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 67. Pain Management Drugs Market in Germany, 2023-2033, $ mn
Figure 68. Pain Management Drugs Market in U.K., 2023-2033, $ mn
Figure 69. Pain Management Drugs Market in France, 2023-2033, $ mn
Figure 70. Pain Management Drugs Market in Spain, 2023-2033, $ mn
Figure 71. Pain Management Drugs Market in Italy, 2023-2033, $ mn
Figure 72. Pain Management Drugs Market in Russia, 2023-2033, $ mn
Figure 73. Pain Management Drugs Market in Rest of Europe, 2023-2033, $ mn
Figure 74. Asia-Pacific Pain Management Drugs Market, 2023-2033, $ mn
Figure 75. Growth Opportunity Analysis of Asia-Pacific Market by Country
Figure 76. Breakdown of APAC Pain Management Drugs Market by Country, 2023 and 2033, % of Revenue
Figure 77. Contribution to APAC 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 78. Pain Management Drugs Market in Japan, 2023-2033, $ mn
Figure 79. Pain Management Drugs Market in China, 2023-2033, $ mn
Figure 80. Pain Management Drugs Market in Australia, 2023-2033, $ mn
Figure 81. Pain Management Drugs Market in India, 2023-2033, $ mn
Figure 82. Pain Management Drugs Market in South Korea, 2023-2033, $ mn
Figure 83. Pain Management Drugs Market in Rest of APAC, 2023-2033, $ mn
Figure 84. South America Pain Management Drugs Market, 2023-2033, $ mn
Figure 85. Growth Opportunity Analysis of South America Market by Country
Figure 86. Breakdown of South America Pain Management Drugs Market by Country, 2023 and 2033, % of Revenue
Figure 87. Contribution to South America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 88. Pain Management Drugs Market in Argentina, 2023-2033, $ mn
Figure 89. Pain Management Drugs Market in Brazil, 2023-2033, $ mn
Figure 90. Pain Management Drugs Market in Chile, 2023-2033, $ mn
Figure 91. Pain Management Drugs Market in Rest of South America, 2023-2033, $ mn
Figure 92. Pain Management Drugs Market in Middle East and Africa (MEA), 2023-2033, $ mn
Figure 93. Growth Opportunity Analysis of MEA Market by Country
Figure 94. Breakdown of MEA Pain Management Drugs Market by Country, 2023 and 2033, % of Revenue
Figure 95. Contribution to MEA 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 96. Pain Management Drugs Market in UAE, 2023-2033, $ mn
Figure 97. Pain Management Drugs Market in Saudi Arabia, 2023-2033, $ mn
Figure 98. Pain Management Drugs Market in South Africa, 2023-2033, $ mn
Figure 99. Pain Management Drugs Market in the Rest of MEA, 2023-2033, $ mn
Figure 100. Growth Stage of Global Pain Management Drugs Industry over the Forecast Period
Figure 101. Comparison of Risk Factors by GMD RIN in 2023
Figure 102. GMD Relative RIN of Internal Risk Factors in 2023 on Radar Chart
Figure 103. GMD Relative RIN of External Risk Factors in 2023 on Radar Chart
